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ABSTRACT 
During host–pathogen interactions, a complex web of events is crucial for the outcome of 
infection. Pathogen recognition triggers powerful cellular signaling events that is translated 
into the induction and maintenance of innate and adaptive host immunity against infection. In 
opposition, pathogens employ active mechanisms to manipulate host cell regulatory pathways 
toward their proliferation and survival. Among these, subversion of host cell energy 
metabolism by pathogens is currently recognized to play an important role in microbial growth 
and persistence. Extensive studies have documented the role of AMP-activated protein kinase 
(AMPK) signaling, a central cellular hub involved in the regulation of energy homeostasis, in 
host–pathogen interactions. Here, we highlight the most recent advances detailing how 
pathogens hijack cellular metabolism by suppressing or increasing the activity of the host 
energy sensor AMPK. We also address the role of lower eukaryote AMPK orthologues in the 
adaptive process to the host micro-environment and their contribution for pathogen survival, 
differentiation, and growth. Finally, we review the effects of pharmacological or genetic AMPK 
modulation on pathogen growth and persistence. 
INTRODUCTION 
Adenosine 5’monophosphate‐activated protein kinase (AMPK) is a 
heterotrimericserine/threonine kinase consisting of a catalytic subunit (α) and two regulatory 
subunits (β and γ) (Xiao et al. 2011). AMPK is considered a pivotal regulator of cellular 
metabolism known as a metabolic “master regulator,” switching on catabolic pathways that 
generate ATP, while switching off anabolic pathways that consume ATP. Therefore, upon 
activation, AMPK downregulates several anabolic enzymes through phosphorylation leading 
to the inhibition of both translation initiation by restraining mammalian target of rapamycin 
complex 1 (mTORC1) activity, as well as translation elongation through the inactivation of 
Eukaryotic Elongation Factor 2 (eEF2), which will ultimately decrease cellular ATP 
consumption. In opposition, AMPK activates a catabolic state by inducing oxidative pathways 
generating energy through the activation of glucose uptake (via activation of both glucose 
transporter 1 (GLUT1) and GLUT4) (Barnes et al. 2002; Holmes et al. 1999), glycolysis (via 
phosphorylation and activation of two of four isoforms of 6-phosphofructo-2-kinase) (Marsin et 
al. 2002), fatty acid uptake (via translocation of the fatty acid transporter FAT/CD36) (Bonen et 
al. 2007), and fatty acid oxidation (via phosphorylation of the isoform 2 of acetyl-CoA 
carboxylase (ACC2)) (Winder and Hardie 1996). Classically, the canonical upstream activator 
that phosphorylates AMPK on Thr 172 (Stein et al. 2000) is the constitutively active tumor 
suppressor liver kinase B1 (LKB1) accompanied by two accessory subunits, sterile 20 protein‐
related adaptor (STRAD) and mouse protein 25 (MO25) (Hawley et al. 2003; Woods et al. 
2003), but additional activators such as the Ca
2+
-calmodulin-dependent kinase kinase 
(CaMKK) has been also identified (Woods et al. 2005; Hawley et al. 2005).  
AMPK is capable of sensing changes in the energy status of the cell, and therefore it is not 
surprising that it plays a pivotal role during infections (Moreira et al. 2015b). Nutritional 
immunity has been described as a defence mechanism employed by host cells to prevent the 
acquisition of essential nutrients by intracellular pathogens, thus preventing pathogen 
scavenging and further utilization for replication and survival (Hood and Skaar 2012). 
Furthermore, recent advances have underlined the role of AMPK in macrophage, T cell, and 
DC functions in distinct settings, providing a molecular link between bioenergetics 
homeostasis, viability, and effector functions of adaptive and innate immune cells (Blagih et al. 
2015; Kelly and O’Neill 2015; Yang and Chi 2015). These concepts are the core of host–
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pathogen dynamics. Herein, we review the contribution of AMPK sensor in regulating viral, 
bacterial, parasitic, and fungal infections. Furthermore, given the high degree of conservation 
among eukaryotes, we intend to discuss the crucial role of AMPK in parasites and fungi. The 
most recent findings concerning the AMPK role in the parasite and fungal biology during host–
pathogen interaction will be also addressed. 
AMPK: A REGULATOR OF VIRAL INFECTION 
Modulation of AMPK Activity by Viruses 
Simian virus 40 (SV40) is a polyoma virus that encodes for small and large T antigens 
implicated in tumor formation. SV40 small T antigen has been shown to protect human cells in 
glucose deprivation. This survival advantage for cancer cells was demonstrated to be 
correlated with an increased phosphorylation of AMPK and consequent downregulation of 
mTORC1, which ultimately triggered autophagy (Kumar and Rangarajan 2009). In vitro 
infection with avian reovirus (ARV) resulted in an increase in AMPK phosphorylation on 
Thr172 (Ji et al. 2009) and a concomitant increase in mitogen-activated protein kinase 
(MAPK) p38 phosphorylation. AMPK phosphorylation has also been described to be 
increased early after infection with Rift Valley fever virus (RVFV), an important reemerging 
arthropod-borne human pathogen (Moser et al. 2012). 
On the contrary, infections with Hepatitis C virus (HCV), Human cytomegalovirus (HCMV), 
Herpes simplex virus (HSV), Epstein–Barr virus (EBV), and human immunodeficiency virus-1 
(HIV-1) have been reported to inhibit AMPK activity. In this context, cells infected with HCV or 
harboring an HCV subgenomic replicon inhibited the phosphorylation of AMPK at Thr172. This 
was consistent with the concomitant reduction on AMPK activity and increased hepatic lipid 
accumulation required for virus replication (Mankouri et al. 2010). Inhibition of Thr172 
phosphorylation was associated with an increased phosphorylation of AMPK at an alternative 
site, Ser485, which is phosphorylated by protein kinase B (PKB/Akt) (Horman et al. 2006). 
Interestingly, both HCV NS4B and NS5A proteins have been shown to activate the protein 
kinase AKT (Park et al. 2009; Street et al. 2004). In addition to HCV, HCMV, a beta herpes 
virus that establishes chronic infections, activates mTOR signaling by inhibiting AMPK Thr172 
phosphorylation at early time points postinfection (Kudchodkar et al. 2007). Interestingly, at 
later time points of infection, a kinome RNAi screen performed in HCMV-infected MRC5 
fibroblasts identified 106 cellular kinases that influenced the growth of the virus, including 
multiple elements of the AMPK pathway (Terry et al. 2012). The effector proteins responsible 
for the AMPK inhibition still remain elusive, although the inhibition of CaMKK was reported to 
block HCMV-mediated AMPK activation (McArdle et al. 2011, 2012). Furthermore, it has been 
shown that HCMV blocked the function of the mitochondrial trifunctional protein (TFP), a key 
enzyme during fatty acid-β-oxidation (Seo and Cresswell 2013), through the redistribution of 
viperin to the mitochondria. The resulting decrease in cellular ATP levels and consequent 
increase in AMP-activated AMPK. The latent membrane protein 1 (LMP1) encoded by EBV, 
which is associated with the development of nasopharyngeal carcinoma, inhibited the 
phosphorylation of LKB1 at serine 428 leading to the inhibition of AMPK phosphorylation 
(Plummer et al. 2013). 
Sirtuin 1 (SIRT1), a nicotinamide adenine dinucleotide-dependent class III protein 
deacetylase, and AMPK are activated during the cellular response to nutrient deprivation and 
exhibit a reciprocal regulation (Fulco et al. 2008). In the context of HCV core protein 
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expression in HepG2 cells, it has been shown that the activity of SIRT1 along with AMPK is 
decreased (Yu et al. 2013). In the context of HIV infection, it has been proposed that the 
transactivator Tat protein mediates its effect on AMPK via the inhibition of SIRT1 (Zhang and 
Wu 2009). However, a certain complexity is associated with the fact that SIRT1 deacetylates 
Tat (Pagans et al. 2005) and Tat inhibits SIRT1 (Kwon et al. 2008). More recently, it has been 
proposed that curcumin reversed Tat-mediated reduction in AMPK activation and downstream 
ACC activation (Zhang et al. 2011). Therefore, the relationship between HIV infection and 
AMPK modulation merits to be further explored in the context of viral infection. 
Role of AMPK in Virus Entry and Replication 
Since some viruses manipulate host AMPK toward immune evasion, a valuable therapeutic 
antiviral strategy may pass through the pharmacological manipulation of AMPK activity. In this 
context, Vaccinia virus infects a wide range of host cells, and all three subunits of AMPK 
facilitated virus entry (Moser et al. 2010). AMPK is involved in poxvirus entry in a manner that 
is independent of its role as a metabolic regulator. The authors point to a novel role of AMPK 
in promoting macropinocytosis and cellular motility by regulating actin dynamics, 
independently of LKB1 or CaMKK (Moser et al. 2010). AMPK deficiency attenuated vaccinia 
infection by interfering with viral entry. This supports the development of selective AMPK 
inhibitors or other inhibitors of macropinocytosis against poxviruses, as well as for other 
viruses that hijack this endocytic route for their entry mechanism. In vitro treatment of 
hepatoma cells with the AMPK activator 5-aminoimidazole-4-carboxamide 1-β-D-
ribofuranoside (AICAR) was shown to suppress HCV replication (Nakashima et al. 2011; 
Mankouri et al. 2010). The importance of AMPK in HCMV replication is supported by the 
observation that the inhibition of AMPK kinase with compound C attenuates early and late 
HCMV replication (Hutterer et al. 2013; McArdle et al. 2012; Terry et al. 2012). Moreover, the 
addition of 2-octynoic acid (2-OA) to HCV-infected cells inhibited viral replication in a process 
involving the activation of AMPK and the inhibition of ACC, the first rate-limiting enzyme in 
fatty acid synthesis (Yang et al. 2013). Importantly, it has been shown that AMPK and its 
upstream activator LKB1 are essential for the control of RVFV infection, which is associated 
with the phosphorylation and inhibition of ACC. Treatment with the fatty acid palmitate 
bypasses this restriction, demonstrating that AMPK restricts RVFV infection through its 
inhibition of fatty acid biosynthesis (Moser et al. 2012). Furthermore, the authors showed that 
AMPK restricts the growth of multiple arboviruses from disparate families, including the 
Flavivirus Kunjin virus (KUNV), the Togavirus Sindbis virus (SINV), and the Rhabdovirus 
Vesicular stomatitis virus (VSV) (Moser et al. 2012). Therefore, this process represents a 
novel mechanism of interest regarding viruses’ control mechanisms. Because many viruses 
require complex and unique interactions with cellular lipid metabolism through both synthesis 
and degradation pathways, it cannot be excluded that viruses inhibit AMPK activation in order 
to stimulate lipid synthesis within the infected cells. Thus, AMPK activation is broadly antiviral 
and may provide a novel antiviral therapeutic target. 
Finally, it has been proposed that AMPK is involved in the reactivation of latent viruses, such 
as HIV-1, through bryostatin-induced activation, a protein kinase C activator (Mehla et al. 
2010). This was further confirmed by the use of compound C that partially reduced HIV-1 
reactivation. In the same study, the authors showed that metformin, an oral antidiabetic drug 
that activates AMPK indirectly through mitochondrial complex I inhibition (Zhou et al. 2001), 
inhibits HIV-1 replication. These results underline differential effects either on the reactivation 
of HIV-1 or the productive viral replication (Mehla et al. 2010). Furthermore, metformin also 
inhibits in vitro HCV replication (Huang et al. 2013). The addition of metformin to current HCV 
treatment regimens had promising, albeit modest, effects on reducing patient viral loads 
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(Romero-Gomez et al. 2009). Moreover, several AMPK activating drugs have been shown to 
reduce morbidity and mortality during lethal influenza infection in mice (Moseley et al. 2010). 
AMPK and Autophagy During Viral Infections 
Autophagy becomes particularly important during cellular starvation as a means to recycle 
amino acids and cellular components for use as catabolic fuels. mTOR forms two functionally 
distinct complexes in mammals, mTORC1 and mTORC2. In particular, mTORC1 senses 
nutrient deprival. This is an essential information to take into account when addressing host–
pathogen interactions, given that AMPK is an established negative regulator of the mTOR 
signaling cascade (Inoki et al. 2003; Shaw et al. 2004). AMPK can directly phosphorylate 
Raptor, a positive regulatory subunit of the mTORC1 complex, and, in addition, it has been 
shown that AMPK phosphorylates the protein kinase UNC-51-like kinase 1 (ULK1), which is a 
key signaling complex required for autophagosome formation (Egan et al. 2011; Kim et al. 
2011). During the last two decades, autophagy has been analyzed more in detail and 
described to regulate host–pathogen interactions. Growing evidences indicate that autophagy 
acts both in the antiviral and proviral pathway (Rey-Jurado et al. 2015; Santarelli et al. 2015). 
Viral infections may result in the inhibition of host cell metabolism, thus leading to a 
concomitant reduction in energy demands. This could happen either by blocking host cell 
protein synthesis, while in the opposite way, by placing increased energetic demands upon 
infection, which might result in an activation of AMPK. Further studies are necessary to 
assess the contributing role of the AMPK pathway in regulating autophagy in the context of 
viral infections. Therefore, it cannot be excluded that AMPK is a critical regulator of cell 
autophagy in the context of host–pathogen interactions that need to be further addressed. 
AMPK and Immune Effector Functions Cells During Viral Infection 
Immune response against pathogens and in particular viruses leads to a rapid modification of 
cellular metabolism. It has been initially identified that signal transduction pathways, which 
modulate T-cell metabolism, involve LKB1 and AMPK as key regulators (Blagih et al. 2015; 
Blagih et al. 2012). Thus, LKB1-deficient T cells exhibited defects in cell proliferation and 
viability, accompanied by altered glycolytic and lipid metabolism. Interestingly, loss of LKB1 
promoted an increase in T cell activation and inflammatory cytokine production by both CD4+ 
and CD8+ T cells (MacIver et al. 2011). However, although AMPKα1 activity is dispensable for 
proliferation and differentiation of cytotoxic T lymphocytes (CTLs), AMPK knockout (KO) mice 
show a striking defect in their ability to generate memory CD8+ T-cell responses in vivo, along 
with a lower survival of CTLs following withdrawal of immune stimulation (Rolf et al. 2013). 
The role of metformin has also been addressed in arthritis. It was recently shown that the 
attenuation of the disease in AMPK KO mice could result from decreased levels of pro-
inflammatory cytokines. Interestingly, the impact of AMPK on the differentiation of T cells into 
T helper 17 (Th17) cells upon stimulation was also demonstrated (Kang et al. 2013). Recently, 
it has been demonstrated that AMPKα1 is essential for Th1 and Th17 cell development and 
primary T cell responses to viral and bacterial infections. A reduction of both Th1 and Th17 
responses (Estaquier et al. 1996; Estaquier et al. 1995; Raffatellu et al. 2008; Brenchley et al. 
2008; Cecchinato et al. 2008; Campillo-Gimenez et al. 2010) were associated with a higher 
propensity of the cells to die by apoptosis observed during the course of HIV-1 infection 
(Estaquier et al. 1994; Monceaux et al. 2003; Hurtrel et al. 2005; Cumont et al. 2007). This 
originates the question as whether or not metformin could restore functional immune effector 
T cells through AMPK activation and if this approach could have potential interest in the 
development of therapeutic strategy against acquired immunodeficiency syndrome (AIDS). 
Thus, given the critical role played by CD4+ and CD8+ T cells in controlling viruses, regulation 
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of metabolic homeostasis represents a quite remarkable field to explore in the context T cell 
immunity. 
In addition to adaptive immunity, a role for AMPK in regulating innate immunity has been 
proposed. AMPK activation promotes macrophage polarization toward an anti-inflammatory 
M2 phenotype (Sag et al. 2008) and modulates inflammatory gene expression through 
activation of SIRT1 (Yang et al. 2010b). However, one important effect of AMPK is the 
suppression of signal transducers and activators of transcription 1 (STAT1) signaling induced 
by interferon-gamma (IFN-γ), which inhibits inflammation and chemokines in primary 
astrocytes and microglia (Meares et al. 2013). This could be particularly important in the 
context of neuronal infections because inflammation in the central nervous system contributes 
to neurologic disorders. Furthermore, type I IFN-derived immune responses, which are 
essential for controlling virus spread, decreases the phosphorylation of AMPK. Consistently, 
metformin enhances the antiviral effect of IFN-β in Coxsackievirus B3 virus infection (Burke et 
al.2014). It has been also proposed that 2-OA antiviral activity against HCV is associated with 
AMPK activation, through induction of interferon stimulated genes (ISGs) and the inhibition of 
miR-122 expression (Yang et al. 2013). In the context of RVFV, however, the authors have 
excluded a role of type I IFN in regulating virus infection downstream AMPK (Moser et al. 
2012). Therefore, AMPK appears to be a central player in regulating innate and adaptive 
immune responses, which are essential in controlling viral infections. Figure 12.1 illustrates 
the differential regulation of AMPK activity by viruses. 
AMPK IN THE CONTROL OF BACTERIAL INFECTION 
Pathogenic intracellular bacteria infect their hosts by exploiting its cytoplasmic milieu toward 
survival, growth, and dissemination. During infection, intracellular bacteria must compete 
with the host in order to obtain the necessary energy and carbon sources. The specific 
scavenge of nutritional sources by the bacteria may increase their survival odds and 
consequently can be detrimental to the survival of the permissive host. In parallel, the host 
cell is forced to respond vigorously to the internal threat by using specific microbicidal 
mechanisms at the same time that need to maintain bioenergetic homeostatic levels to 
prevent failure and death. Yet, AMPK beneficial or prejudicial role during bacterial infections 
appears to be pathogen-specific (Fig. 12.2). 
Autophagy: Is Self-Eating Saving or Killing the Bacteria? 
Such as in the context of viral infections, it has been shown that selective recognition of 
intracellular bacteria and their targeting to the autophagic machinery for degradation in 
lysosomes, also referred as xenophagy, is of crucial importance for bacterial control (Cemma 
and Brumell 2012). Xenophagy has been put forward as a key component of cell-autonomous 
innate immunity defence mechanisms against infections (Sorbara and Girardin 2015). If in one 
hand, xenophagy may contribute to pathogen elimination, in the other, it may also provide the 
necessary intracellular metabolites that sustain pathogen growth. Amino acid (AA) starvation 
induced by bacterial pathogens is sensed by the host to trigger protective innate immune and 
stress responses. The bacteria Shigella and Salmonella are able to trigger an acute AA 
starvation in HeLa cells, as a consequence of host membrane remodeling and damage. Thus, 
the AA depletion led to the inhibition of the mTOR pathway emphasizing a possible activation 
of AMPK (Tattoli et al. 2012). Francisella tularensis is an example of a cytosolic bacterium that 
activates host autophagic system to increase cytosolic pools of nutrients for its own advantage 
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(Steele et al. 2013). On the other hand, bacterial pathogens have suffered selective pressure 
leading to the acquisition of skills to manipulate the host enzymatic machinery in their own 
advantage. In this sense, bacteria can not only prevent the initiation of autophagic 
mechanisms and maturation of phagosomes, but they are also able to use some components 
of xenophagy toward its replication and survival (Levine et al. 2011; Deretic et al. 2013). 
Mycobacterium tuberculosis (Mtb) and Yersinia pseudotuberculosis represent well this last 
group. Y. pseudotuberculosis can replicate inside autophagosomes, which are blocked in their 
maturation and thus unable to fuse with lysosomes (Moreau et al. 2010). M. tuberculosis is 
capable of evading autophagy in macrophages through the inhibition of xenophagic pathways 
(Kumar et al. 2010). In this case, treatment with Isoniazid, a first-line drug against 
tuberculosis, during the first 24 h of infection is capable to restore autophagy in M. 
tuberculosis-infected bone marrow-derived macrophages (BMDMs) in an AMPK-dependent 
manner leading to pathogen elimination (Kim et al. 2012).  
Nonetheless, the replenishment of essential substrates for the pathogen may be assured 
through modulation of AMPK activity (Brunton et al. 2013). Mycobacterium tuberculosis is 
capable of utilizing fatty acids as the major energy source (Rhee et al. 2011). While fatty acids 
and cholesterol are viewed as the predominant carbon source throughout infection (Lee et al. 
2013; McKinney et al. 2000; Munoz-Elias and McKinney 2005; Pandey and Sassetti 2008), 
triglycerides could represent an energetic reservoir during bacteria dormancy (Daniel et al. 
2004). M. tuberculosis is capable of inhibiting AMPK and activating mTOR by inducing lipid 
synthesis. It was recently shown that Mtb accumulated intracellular triacylglycerides (TAG) 
whose composition is nearly identical to host TAG. Accordingly, it was demonstrated that Mtb 
TAG were synthesized using free fatty acids released from host macrophages. This lipid 
scavenging created an energetic reservoir that ultimately allows the bacteria to enter in a 
latent stage (Daniel et al. 2011). Recently, these kinases arose as a potential trigger of 
autophagy during infection. Escherichia coli (ETEC) exploits host’s autophagic machinery 
through the inhibition of mTOR pathway and ERK1/2 and AMPK phosphorylation (Tang et al. 
2014). Similarly, the peroxisome proliferator-activated receptor-gamma coactivator 1α 
(PPARGC1A)-dependent activation of AMPK in M. tuberculosis infection results on increased 
transcription of autophagy-related genes via CCAAT/enhancer binding protein β (CEBPB). 
This activation was also associated with increased mitochondrial respiration and biogenesis 
(Yang et al. 2014). TLR 1/2 has been associated with the initiation of autophagic mechanisms 
during mycobacterial infections (Yuk et al. 2009). This was shown to be mediated by the 
mycobacterial lipoprotein LqpH, which activates TLR1/2 inducing a rapid and transient 
increase in intracellular calcium concentration leading to AMPK activation, possibly through 
upstream activation of CaMKK. Furthermore, AMPK activation was shown to be essential for 
autophagy, resulting in the phosphorylation of p38-MAPK (Shin et al. 2010). Similarly to LqpH, 
pore-forming toxins (PFT) are bacterial virulence factors that have been implicated in the 
prompting of autophagy, although the underlining mechanisms remain elusive (Gonzalez et al. 
2008). Kloft and colleagues observed that several PFT (streptolysin O, Vibrio cholera 
cytolysin, Staphylococcus aureus α-toxin, and Escherichia coli haemolysin A) cause a drop in 
intracellular ATP levels leading to AMPK activation (Kloft et al. 2010). It has been 
hypothesized that the formation of membrane pores leads to the activation of downstream 
targets, as the AMPK signalling pathway, which may contribute for the maintenance of cellular 
homeostasis. 
Further studies suggest that AMPK signaling may regulate and facilitate the intracellular 
replication of this pathogen. Although xenophagy may be presented as an antibacterial 
mechanism, it is important to reckon that other evasion mechanisms driven by a chronic 
activation of AMPK in the infected cells can be used by invading bacteria, such as Salmonella, 
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to subvert the immune response (Tattoli et al. 2012). Likewise, Legionella pneumophila, the 
causative agent of Legionnaires disease, is capable of inhibiting the phagosome-lysosome 
fusion, in order to subvert host cell immune response (Horwitz 1983). Macrophage 
mitochondria and endoplasmic reticulum-derived vesicles are recruited to the vicinity of the 
phagosome within the first minutes of L. pneumophila infection (Tilney et al. 2001). The 
consequent encapsulation of Legionella-containing phagosomes increases the survival odds 
of this bacteria, since it prevents its fusion with lysosomes or acidifying vesicles. This 
subservient mechanism clearly suggests the utilization of mitochondria and other organelles 
for support in early stages of infection. Francione et al. (2009) using a Dictyostelium 
discoideum model for mitochondrial disease observed a faster growth and higher bacterial 
burden in mitochondrial disease strains. AMPK activation may also be beneficial for 
Helicobacter pylori and Neisseria meningitides infections. These gram-negative bacteria 
colonize the gastric mucosa causing several local distresses as gastritis, gastric ulcers, or 
gastric cancer. AMPK activation during gastric epithelial cells (GEC) cell infection is induced 
by transforming growth factor-β (TGF-β)-activated kinase 1 (TAK1), resulting in decreased 
apoptosis of GEC cells and consequent bacterial survival (Lv et al. 2014). The decreased 
level of apoptosis originates persistence of infection and GEC proliferation, contributing to the 
development of carcinogenesis. Accordingly with these results, administration of 
compound13, a novel α1-selective activator of AMPK, was shown to decrease H. pylori-
induced GEC apoptosis through reactive oxygen species (ROS) scavenging and activation of 
the AMPK-heme oxygenase (HO-1) pathway (Zhao et al. 2015). Similarly, activation and 
overexpression of AMPK improve human brain microvascular endothelial cells (HBMECs) 
permeability after a challenge with lipopolysaccharide (LPS) through suppression of the 
induction of NAD(P)H oxidase-derived ROS (Zhao et al. 2014). AMPK was activated at 24 h 
postinfection, while PKB-Akt protein analysis showed dephosphorylation and thus inactivation 
(Schubert-Unkmeir et al. 2007). In spite of being demonstrated that N. meningitides regulates 
gene transcription, translation, and cell metabolism, it is necessary to understand the 
virulence factors involved. 
Bacterial Host Immune Response: A Double-Edge Sword Controlled by 
AMPK 
Nutrient availability is an important factor when evaluating effector T cell function, since their 
dysfunction can impair the appropriate responses that culminate with pathogen elimination. 
Mice with T cell-specific deletion of AMPKα1 infected with an overexpressing OVA Listeria 
monocytogenes showed a decreased number of total CD4+ and CD8+ T cells at 7 days 
postinfection. Not only their numbers were reduced as their effector function, since ex vivo 
stimulation of infected splenocytes in the conditional KO mice displayed lower levels of IFNγ+ 
(Blagih et al. 2015). This work highlights the importance of AMPK in allowing the proper 
function of T cells in response to pathogens, which is ultimately connected to the metabolic 
pathways established in these cells. ROS production is one of the hallmarks of innate host 
response against intracellular pathogens. Concomitant administration of the AMPK inhibitor 
compound C with LPS originated an impaired immune response to endotoxemia via the 
decrease of nuclear-factor kB (NF-kB) activation pathway. This was correlated with a 
decreased chemotaxis of macrophages and neutrophils to the liver, with decreased ROS 
production and TNFα levels in the serum (Guo et al. 2014). Furthermore, upon AMPK 
activation, neutrophils showed an enhancement in E. coli and S. aureus uptake and 
consequent killing. These observations were supported in vivo using murine models for 
peritonitis-induced sepsis where metformin-treated mice were found to have fewer viable 
bacteria (Park et al. 2013). In opposition, in tuberculosis (TB) patients, AMPK-expressing 
neutrophils were shown to be able to secrete higher quantities of metalloproteinase-8 (MMP-
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8), in a NF-kB-dependent fashion, leading to matrix destruction and collagen. This study 
demonstrated that AMPK activation has a role in the secretion of MMP-8 contributing to lung 
immunopathology during M. tuberculosis infection (Ong et al. 2015). In a very elegant work, 
Chakrabarti et al. showed that the disruption of Drosophila flies gut homeostasis upon 
Pseudomonas entomophila infection was caused by the impairment of barrier repair 
pathways. The mechanism of subversion of gut immune response was mediated by an 
activation of AMPK-Tuberous sclerosis complex (TSC) stress pathways, which are 
responsible for TOR inhibition and consequent repression of host translation mechanisms. 
Ultimately, this contributes to the entrance of infected cells in a quiescent state, more prone 
for tissue repair but that also allows P. entomophila survival (Chakrabarti et al. 2012). 
Modulation of Host AMPK as a Pharmacological Approach to Target 
Bacterial Infection 
Metformin treatment restricts the intracellular growth of multidrug-resistant Mycobacterium 
tuberculosis strains in THP-1 and human monocyte-derived macrophages through 
mitochondrial ROS induction. Moreover, metformin administration ameliorates lung pathology 
and reduces chronic inflammation while enhancing the efficacy of conventional anti-
tuberculosis drugs (isoniazid and ethionamide) in mice models of acute and chronic 
tuberculosis. In this retrospective study, metformin treatment was associated with improved 
control of infection and decreased disease severity (Singhal et al. 2014). Moreover, 
administration of metformin suppresses the inflammatory effects of LPS via induction of 
activating transcription factor-3 (ATF-3) and AMPK activation. Thus, mice with LPS-induced 
endotoxemia treated with metformin displayed lower levels of IL-6 and TNF-α, thus decreasing 
inflammation in vivo (Kim et al. 2014). Furthermore, metformin-induced activation of AMPK 
inhibited the release of high mobility group box 1 (HMGB1), a protein involved in severe 
sepsis. This inhibition originated the observed anti-inflammatory effect in LPS-treated 
RAW264.7 macrophages and in endotoxemic mice, characterized by decreased levels of IL-6, 
TNF-α, IL-1β, prostaglandin E2 (PGE2), and nitric oxide (NO) (Tsoyi et al. 2011). The 
activation of AMPK can also be obtained by treatment with AICAR. Similarly, in vivo treatment 
with this drug resulted in decreased lipoteichoic acid (LTA)-driven lung inflammation 
(Hoogendijk et al. 2013). Using cecal ligation and puncture (CPL) as a model of sepsis, it was 
shown that AICAR prevented CLP-induced liver and kidney damage. Additionally, AMPK 
inhibition in hepatic and renal cells with compound c exacerbated cytokine production and 
prevented autophagy, thus culminating in increased tissue injury (Escobar et al. 2015). The 
role of a new bioactive lignan, sauchinone, in AMPK modulation has been studied. The 
activation of LKB1-AMPK pathway by this anti-inflammatory molecule has been shown to 
decrease liver toxicity through prevention of iron accumulation (Kim et al. 2009). Recently, 
Jeong and colleagues explored the role of sauchinone-induced AMPK activation in 
macrophage phagocytosis (Jeong et al. 2014). The authors demonstrated that sauchinone 
increased phosphorylation of AMPK and p38 MAPK, which correlated with increased E. coli 
phagocytic uptake by macrophages in mice lungs. 
INTERACTION BETWEEN AMPK AND PARASITES 
Host–Parasite Nutrient Sensing 
All the organisms have the ability to sense their surroundings in search for nutrients through a 
variety of strategies that have evolved to suit the particular needs of each living form. In 
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particular, protozoan parasites need to adapt to more than one host to survive and multiply. 
Therefore, a dynamic interplay between the host and the parasite is necessary to efficiently 
coordinate the various parasite developmental stages. The best example would be the 
maintenance of limited parasite density inside the host or in a distinct host niche that will be 
responsible for initiating a specific response by ensuring space and nutrients to the entire 
parasite community (Mony and Matthews 2015; van Zandbergen et al. 2010). This is quite 
remarkable in African trypanosomes, Trypanosoma brucei spp., where a morphological and 
molecular alteration into a “slender” form without proliferative capacity is critical to restrain 
parasitemia and also to have an efficient transmission to the insect host (Gjini et al. 2010; 
Vassella et al. 1997; Vickerman 1985). Moreover, the confirmed presence of programmed cell 
death (PCD) in parasites such as Tetrahymena thermophila, Leishmania spp., Trypanosoma 
cruzi, Plasmodium spp., Trypanosoma brucei, Giardia lamblia, Dictyostelium discoideum, 
Trichomonas vaginalis, Peridinium gatunense, and Blastocystis hominis (Al-Olayan et al. 
2002; Ameisen et al. 1995; Pollitt et al. 2011; Rousset and Roze 2007; Zangger et al. 2002) is 
another mechanism to control parasite density. As a result, the premature death of host or 
vectors is prevented and the right number of parasites are then able to dampen the host 
immune system and avoid the limitation of nutrients and resources (Ameisen et al.1995; 
Reece et al. 2011). Thus, nutrient availability is a key factor for parasite fitness during 
infection. 
These mechanisms will ultimately ensure a physical space and a nutrient-rich niche that 
support parasite survival and high growth rate, while maintaining the viability of its host 
reservoir. During the evolutionary process, unicellular organisms developed strategies to 
sense extracellular nutrients and intracellular metabolite concentrations since they are often 
exposed to relevant variations. Some nutrient sensing pathways, as chemoreceptors and PII 
proteins in bacteria, MEP2 sensor, SPS pathway, and Snf3/Rgt2 sensors in fungi and PII 
proteins in plants, are unique for these organisms. Such pathways respond to nitrogen, amino 
acids, ribose, galactose, glucose, and ammonium fluctuations (Chantranupong et al. 2015). 
Three important pathways, highly conserved from yeast to man, are responsible to sense 
different nutrient pools. These are general amino acid control non-derepressible 2 (GCN2), 
TOR kinase and AMPK. Amino-acid levels are sensed by GCN2 and mTOR, while glucose is 
regulated by mTOR and AMPK and energetic fluctuations are uniquely controlled by AMPK 
(Chantranupong et al. 2015). Thus, while host and parasites can actually share some nutrient 
sensors, this section will focus only in AMPK. 
AMPK in the Context of Parasite Infection: Host–Parasite Nutrient Dynamics 
The exquisite host–parasite interaction is the result of a coevolution network that has been 
established continuously since the very first ancient association. The parasite and host 
coevolution has been developed in parallel throughout time although parasites possess an 
advantage due to their shorter generation time and to the higher growth rate. To preserve its 
higher proliferative capacity, parasites have to acquire nutrients from the host, its nutritional 
requirement being one of the key features in the host–parasite interaction. Within host 
parasite this dynamic, a nutrient competition is established between the manipulative parasite 
trying to obtain usable energy and metabolites and the host attempting to sequester the same 
precursors from the pathogen. The heavy metabolic pressure established dictates the parasite 
auxotrophy to several nutrients, the host being the only viable source for acquisition. 
Interestingly, parasites are auxotrophic for several amino acids that are essential for the host. 
The nutritional pressure on extracellular and intracellular parasites is differently exerted. 
Extracellular parasites can salvage the nutrients directly from the extracellular fluids, while 
intracellular parasites need to import nutrients across two or three host membrane systems. 
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Indeed, intracellular parasites need to gain access to nutrients present in the cytosol or inside 
the intra-vacuolar structures where the threshold levels of amino acids do not match with the 
high demands of these organisms for carbon, nitrogen, and energy to support its high 
proliferative rate (Abu Kwaik and Bumann 2013). However, despite their localization, parasites 
developed several strategies to acquire sufficient nutrients in response to their biological 
needs. Plasmodium spp. (intracellular), T. brucei (extracellular), and Leishmania spp. 
(intracellular) acquire nutrients from their hosts by employing different transport proteins, 
named permeases, located inside their plasma membrane. The nutrients imported from the 
host include hexoses, purines, iron, polyamines, carboxylates, and amino acids. The different 
niches occupied by these parasites in their hosts dictate ultimately the mode of nutrient 
acquisition (Landfear 2011). As an example, during L. major amastigotes persistence in the 
macrophage phagolysosomes, the parasite exploits the macrophage function on extracellular 
matrix turnover and remodeling in terms of internalization and degradation of 
glycosaminoglycans (hyaluronan). This mechanism constitutes another process to exploit 
additional nutrients such as amino sugars as a carbon source. The dependency of Leishmania 
on a higher nutrient variety suggests a nutritional diversity inside phagolysosomes that could 
ultimately represent an advantage to colonize such harsh environment (Naderer et al. 2015). 
The response of the host against the diversion of nutrients by the parasite is through the 
restriction of parasite access to nutrient sources. Thus, the process of nutritional immunity 
limits the availability of iron, zinc, and manganese from the invading pathogens (Crawford and 
Wilson 2015). An iron-depleted niche is established during L. major infection through the 
transporter NRAMP1 located at the phagolysosomal compartment. Indeed, NRAMP1 mutation 
renders the host macrophages more susceptible to Leishmania infections (Appelberg 2006; 
Forbes and Gros 2001). The strategies developed by the host and parasite in terms of 
nutrients dynamic will impact the infection outcome. 
AMPK on the Core of Host–Parasite Metabolic Coupling 
The nutritional flow established within host–parasite communities will impact the host 
metabolic background. Several reports have become to identify the pathways involved in the 
metabolic manipulation of host metabolism required for intracellular pathogen growth. Recent 
studies with Toxoplasma gondii (MacRae et al. 2012), Trypanosoma brucei (Wang et al. 
2008), Leishmania spp. (Moreira et al. 2015a; Rabhi et al. 2012), Schistosoma mansoni 
(Wang et al. 2008), and Plasmodium berghei (Lietal. 2008) have paved the way to the 
understanding on the molecular mechanisms used by parasites to take advantage of the 
nutritive host resources. At the core of these metabolic dynamic interactions, AMPK was 
identified as having a crucial role to balance the energetic status of the host with a positive or 
negative impact on parasite survival. Nevertheless, the role of AMPK during the metabolic 
host–parasite crosstalk still remains largely unexplored. 
A microarray analysis performed on mice livers of experimental P. berghei infection revealed 
significant variations within genes related to carbohydrate and energetic metabolisms. This 
approach demonstrated an upregulation of gluconeogenesis pathways while glycolysis 
appears downregulated on liver extracts from mice infected with P. berghei. Interestingly, 
these modifications were accompanied by an increase in the energetic sensors, Prkaa2 
(AMPKα) and Prkag2 (AMPKγ) transcripts (Sales-Dias 2011). Analyzing AMPK translational 
levels will be important to clarify the actual role during P. berghei liver stage infection. A 
potential role of AMPK during an experimental model of cerebral malaria (ECM) was recently 
suggested (Gordon et al. 2015). The mTOR inhibitor rapamycin protects against ECM when 
administered within the first 4 days of infection. Rapamycin increased survival, blocked the 
breakdown of the blood–brain barrier and brain hemorrhaging, and decreased the influx of 
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both CD4+ and CD8+ T cells into the brain and the accumulation of parasitized red blood cells 
in the brain. The impact of mTOR-controlled metabolic pathways and the recent knowledge 
regarding the activation of metabolic pathways in T cells upon antigen recognition led the 
authors to suggest a possible impact of some metabolic pathways, such as AMPK, in the 
control of this disease. 
An intense inflammatory reaction accompanies infection with Trypanosoma cruzi, the etiologic 
agent of Chagas disease. T. cruzi targets the adipose tissue leading to a release of 
inflammatory cytokines as well as a decrease in adiponectin and PPAR-γ contributing to the 
establishment of an inflammatory niche. Interestingly, given that adiponectin activates AMPK, 
it was suggested that a downregulation of the former could be a evasion mechanism to keep 
AMPK in check and favor parasite growth (Nagajyothi et al.2008). A recent work confirmed a 
protective role for AMPK during T. cruzi infection (Caradonna et al. 2013). A genome-wide 
RNA interference screen identified that a sustained AKT-mTORC1 pathway regulate 
intracellular T. cruzi growth. The maintenance of cellular ATP/ADP ratios at higher levels 
provide a distinct advantage for the parasite-limiting AMPK activity. Further, the acute 
silencing of AMPK catalytic (Prkaa1) or the regulatory subunit (Prkab1) in vitro provides a 
more favorable growth environment for intracellular T. cruzi. Although it has not been 
confirmed in vivo, AMPK inhibition is suggested to contribute for T. cruzi survival.  
Recently, we demonstrated that AMPK is, in contrast, crucial for the establishment of a 
microenvironment more prone for L. infantum survival in macrophages (Moreira et al. 2015a). 
Previous analysis on the transcriptomic signature of L. major-infected macrophages revealed 
that carbohydrate and lipid metabolism were among the most altered pathways during 
infection. Increased mRNA levels of glucose transporters as well as key glycolytic enzymes 
encoding genes, such as hexokinases (Hk), pyruvate kinase M2 (Pkm2), and lactate 
dehydrogenase a (Ldha), were induced in the presence of live but not heat-killed L. major 
promastigotes. L. major also induced a downregulation of a number of genes implicated in the 
tricarboxylic acid (TCA) cycle and oxidative phosphorylation suggesting that infected 
macrophages mainly rely on increased glycolytic flow for energy production. On the other 
hand, L. major led to cholesterol and triglycerides accumulation on infected macrophages by 
enhancing the expression of scavenger receptors involved in the uptake of low-density 
lipoprotein (LDL), inhibiting cholesterol efflux and increasing the synthesis of triacylglycerides 
(Rabhi et al. 2012). The accumulation of lipid droplets in close proximity to parasitophorous 
vacuoles advocates the former structure as a potential high-energy substrate source for the 
intracellular parasite. We further observed that following L. infantum infection, macrophages 
switch from an early glycolytic to an oxidative metabolism, in a process requiring SIRT1 and 
LKB1/AMPK. In the absence of SIRT1 or LKB1, infected macrophages are not able to induce 
AMPK activation leading to an impairment of the metabolic switch. In that sense, AICAR-
induced AMPK activation contributes to parasite survival while inhibition of AMPK using 
compound C resulted in lower parasite numbers in vitro. This phenotype was further 
corroborated in vivo as shown by a significantly reduced parasite burden in mice with a 
myeloid-specific AMPK deficiency (Moreira et al. 2015a). 
Gastrointestinal (GI) nematodes also affect profoundly host metabolism. The infection of 
CD11c-specific AMPKα
–/– 
(DC-AMPK
–/–
) mice with the gastrointestinal roundworm 
Nippostrongylus braziliensis led to a dysregulation of Th2 immune response concomitantly 
with a failure to regenerate tissue damage mediated by the pathogen. Imbalanced responses 
generated in DC AMPK
–/– 
mice were associated with increased Type-1 responses, greater 
numbers of Th17 cells, and defects in the generation of alternatively activated macrophages. 
Therefore, AMPK activity in myeloid cells was shown to regulate host protection against this 
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GI parasite (Nieves et al. 2014). The manipulation of AMPK activities by distinct parasites are 
summarized in Fig. 12.3. Although still insufficient, these examples highlight the strategies 
used by the parasites to explore host resources shedding some light on cellular metabolic 
subversion mechanisms induced by microbe infections within the host. In this context, the 
modulation of AMPK activity has been put forward as a possible therapeutic target against 
parasitic diseases. 
CONSERVATION OF THE AMPK MACHINERY IN EUKARYOTE 
PATHOGENS 
NF1/AMPK Pathways in Parasites 
The AMPK family of protein kinases is highly conserved among eukaryotes. This protein has 
been extensively studied in mammals and yeast, where it was demonstrated to have a huge 
similarity from a structural and functional point of view. The conserved kinase family present in 
yeast and plants is denominated as sucrose non-fermenting 1 (SNF1) and SNF1-related 
protein kinase 1 (SnRK1), respectively (Hardie 2007; Polge and Thomas 2007). Genes 
encoding orthologues of the three domains (α, β, and γ subunits) are described in all 
eukaryotic parasite species and even in the primitive Giardia lamblia, which lacks 
mitochondria (Adam 2000; Hardie et al. 2003). The exception is the obligate intracellular 
parasite Encephalitozoon cuniculi that does not possess an identifiable AMPK orthologue 
(Miranda-Saavedra et al. 2007). 
SNF1 and SnRK1 homologs develop similar functions in what concerns the surveillance of the 
metabolic status in response to nutrient and environmental stress through the induction of 
catabolic processes and a general repression of anabolism. Similarly to these organisms, 
some reports have defined the presence of AMPK/ SNF1 protein kinases in eukaryote 
parasites. The first evidence of the presence of an SNF1 homologue in parasites was 
described in apicomplexa phylum for Plasmodium falciparum (Bracchi et al. 1996). In this 
work, an SNF1 homologous gene defined as PfKIN was found to be increased, at 
transcriptional level, in the gametocyte stage which is involved in the transmission and 
adaptation of the malaria parasite from the human bloodstream to the mosquito midgut. The 
deduced protein sequence of PfKIN contains all the characteristic sequence motifs of the 
eukaryotic protein kinases including the ones involved in ATP-binding, substrate recognition, 
and catalysis. The PfKIN catalytic domain shows 40 % of homology with the SNF1 sequence 
from S. cerevisiae. It is important to underline that no significant amino acid sequence 
similarities to any other proteins were found outside the catalytic domain. This suggests that 
PfKIN can be modulated by other signals that differ from the ones found in other eukaryotes 
(Bracchi et al. 1996). A systematic functional analysis of protein kinases in P. berghei 
identified a SNF1/KIN protein. This orthologue was shown to be relevant for sporozoite 
development, particularly in the egression to the salivary gland of the mosquito Anopheles 
stephensi, acting as a regulator of energy metabolism (Tewari et al. 2010). The existence of a 
SNF1/AMPK orthologue was observed in Cryptosporidium parvum (Artz et al. 2011) that lacks 
Krebs cycle and oxidative phosphorylation. In Eimeria acervulina, a putative protein belonging 
to the SNF1 family was identified and correlated with invasion and evasion mechanisms in 
chicken duodenal epithelial cells (Zhang et al. 2015). Finally, still in the apicomplexa phylum, a 
potential AMPK homolog (ToxPK1) was observed in Toxoplasma gondii genome with 58 % 
identity to human AMPK alpha. ToxPK1 gene was shown to be transiently expressed to 
upregulate glycogen biosynthesis during the development of tachyzoites into bradyzoites 
(Ghosh et al. 2012; Ng et al. 1995, 1997). 
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A comparative analysis of the kinomes of representative members of pathogenic 
trypanosomatids, namely Trypanosoma brucei, Trypanosoma cruzi, and Leishmania major, 
have highlighted that AMPK homologues are relatively poorly represented within 
trypanosomatid genomes as compared to humans. Yet, these are predicted to be active 
(Parsons et al. 2005). In T. brucei, the fine-tuned control of transient alteration from the 
“slender” (proliferative) to “stumpy” (quiescent) forms is performed by intracellular signaling 
pathways triggered by the “stumpy induction factor” (SIF). The slender state is retained until 
SIF accumulation reaches threshold levels triggering the nutritional stress-like response, 
which leads to concomitant repression of the “slender retainers” and activation of “stumpy 
inducers.” This dynamic transition leads to cell cycle arrest and prepares the cell for its next 
life cycle stage, in the insect, by reactivating mitochondrial functions required for oxidative 
phosphorylation (Mony and Matthews 2015). A potential role for AMPK in this developmental 
transition can be speculated. The signaling components that drives stumpy formation 
evaluated in a genome-wide RNA interference library screen identified a AMPK/SNF1/KIN11 
homologue. Interestingly, the authors suggest that AMPK homologue, which acts as a SIF, 
could be a potential inhibitor of trypanosomes TORC4 (Mony et al. 2014). TORC4 activity is 
proposed to prevent stumpy formation, since the knockdown of TOR4 drove the cells to 
develop features characteristic of stumpy forms (Barquilla et al. 2012). TOR4 is one of the T. 
brucei TOR paralogues that retain the classical structure of mTOR kinase domains, yet 
displaying new features not described in other TORs (Barquilla et al. 2008). T. brucei procyclic 
forms are able to monitor glucose levels, through the surface molecule expression of 
procyclins, which are crucial for the parasite survive in the tsetse fly vector (Clemmens et al. 
2009). Procyclins are glycoproteins that cover the surface of procyclic forms that are 
suspected to have a protective role against the action of insect proteases (Acosta-Serrano et 
al. 2001). Two major procyclin proteins EP and GPEET were found to be regulated by the 
beta and gamma subunits (TbAMPK beta and TbAMPK gamma, respectively), since the 
silencing of these genes leads to their upregulation. Interestingly, the latter procyclin is highly 
expressed in glucose-deficient environment within tsetse fly. Moreover, the localization of the 
scaffold beta subunit (glycosomes and flagellum) suggests a central positioning between 
surface molecule expression and glycolysis providing thus a molecular connection between 
these two mechanisms (Clemmens et al. 2009). 
It is important to stress out that the role of AMPK/SNF1 protein kinase family are quite similar 
for all the organisms (extracellular or intracellular), playing a central positioning in its most 
relevant pathways. The described AMPK/SNF1 homologues have been implicated in the 
parasite developmental stages that occur within the same host or in different hosts in order to 
recover from a nutrition/energetic depletion status. Parasites have to deal with different 
microenvironments during proliferation and differentiation recurring to sensing mechanisms as 
the AMPK/SNF1 protein kinases that will have definitely a huge impact on parasite fitness. 
SNF1/AMPK Pathways in Fungi 
Over the past years, the incidence of fungal infections has increased in several countries. 
Compared to bacteria, infections caused by fungi are less frequent; nevertheless, their 
treatment is still complicated for systemic infections particularly due to the close functional 
similarity between fungal cells and the host mammalian cells (Navarro-Garcia et al. 2001). 
Human pathogenic fungi encounter a broad range of stress conditions in their natural 
environment as well as in the host during infection that challenge their ability to grow. The 
fungi ability to adapt to a variety of conditions has contributed to the ubiquitous nature in the 
environment and to the success of them as pathogens. In fact, adaptation to nutrient 
fluctuations is crucial for survival. Human pathogenic fungi must adapt to oxidant, pH, or 
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nutritional stress, otherwise they are eliminated by the host defense system. Fungi survival, 
both in the environment or within the human host, requires the activation of signal transduction 
pathways that sense environmental or host stress cues (Hohmann 2002). During host 
nutritional deprivation, fungi pathogens are able to use alternative carbon sources, such 
mechanism being considered a virulence trait crucial to adapt to stress conditions (Lorenz and 
Fink 2001). Therefore, it is not surprising that genes that control several metabolic pathways 
may have a central role in fungal virulence (Navarro-Garcia et al. 2001). 
 
Regulation and Function of Fungi SNF1 Protein Kinase 
Snf1 protein kinase was initially identified by a screening performed with the budding yeast 
Saccharomyces cerevisiae (Celenza and Carlson 1986). Snf1 was identified as the yeast 
homolog of the mammalian AMPK acting as an energy sensor. This kinase, in fungi, is also 
able to reprogram the cellular metabolism through the energetic balance which is essential to 
sustain cell metabolism and to support the development of a stress response (Sampaio-
Marques et al. 2014). S. cerevisiae Snf1 is a serine/threonine protein kinase (α subunit) 
complexed with other proteins, namely γ-activating subunit Snf4 and β subunits Sip1, Sip2, or 
Gal83 depending on Snf1 localization (Celenza and Carlson 1989; Celenza et al. 1989; 
Estruch et al. 1992; Vincent and Carlson 1999). AMPK/Snf1 activation in fungi could be 
dependent or not on AMP/ATP cellular fluctuations. In the former, the allosteric regulation by 
AMP is not crucial for Snf1 activation while in the latter Snf1 function is regulated by cAMP-
dependent protein kinase (PKA) (Ferretti et al. 2012). 
A crucial activity on glucose balance has been also attributed to Snf1 kinase. This is of 
particular importance since glucose is one of the major carbon and energy source for the 
eukaryotic cells. Under carbon stress conditions, fungal cells required the activity of the Snf1 
kinase in order to adapt to this harsh environment. Furthermore, Snf1 activity is requested for 
transcription of glucose repressed genes and increases with aging, even when glucose is 
abundant (Ashrafi et al. 2000; Hedbacker and Carlson 2008). Taken together, Snf1 allows 
cells to adapt to limitations on glucose availability using instead alternative carbon sources, 
such as sucrose, galactose and ethanol (Carlson 1999; Gancedo 1998). Additionally, Snf1 is 
highly important in many other cellular stress conditions helping to establish a response 
against sodium ion stress, heat shock, alkaline pH, and oxidative and genotoxic stress 
(Hedbacker and Carlson 2008). Other crucial biological impact of Snf1 has been described for 
glycogen, sterol, fatty acid biosynthesis, fatty acid-β oxidation, peroxisome biogenesis, and 
ultimately in the fungi sporulation developmental stage (Sanz 2003). The main functions of 
Snf1 kinase in pathogenic fungi are resumed in Fig. 12.4. 
NF1 Protein Kinase in Pathogenic Fungi 
In Candida spp., namely Candida glabrata, the importance of Snf1 kinase for the regulation of 
nutrient sources availability was already demonstrated. Snf1 ablation resulted in the loss of its 
capacity to utilize trehalose, which together with glucose are the carbon sources preferentially 
used by this organism (Petter and Kwon-Chung 1996). In the yeast Cryptococcus 
neoformans, a pathogenic fungus that infects via respiratory tract, particularly 
immunocompromised individuals (Buchanan and Murphy 1998; Hull and Heitman 2002; 
Mitchell and Perfect 1995), the SNF1 abrogation leads to the incapacity to use alternative 
carbon sources such as acetate, ethanol, and sucrose. Furthermore, an increase on 
sensitivity to antifungal drugs such as amphotericin B and to nitrosative stress was also 
detected, manifested particularly at the host temperature of 37ºC (Hu et al. 2008; Yang et al. 
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2010a). In other fungi species such as Aspergillus spp., the absence of SnfA1 (Snf1 
homologue) causes a defect on glucose-depression mechanisms and impairs the pathogen 
growth under various carbon sources. Together, data from the different pathogenic fungi 
suggest that Snf1 presents a conserved function in the regulation of catabolic repression. In 
alignment with this conserved function that allows the cells to adapt to adverse metabolic 
conditions, a role in fungus virulence is also attributed to Snf1, which evidences a regulatory 
connection between carbon source utilization and intracellular growth. In Candida albicans, an 
opportunistic pathogen that is able to invade different tissues of immunocompromised 
individuals causing disease, it was demonstrated that Snf1 is an essential protein. C. albicans 
cells survival depends on the functionality of Snf1 kinase even in the presence of glucose 
(Petter et al. 1997), which goes against what is observed in S. cerevisiae, suggesting a central 
role for Snf1 in C. albicans. However, since SNF1 is an essential gene, its functions in C. 
albicans are still few disclosed. In S. cerevisiae, it was unveiled that Snf1 is able to 
transcriptionally regulate flocullin (FLO11), which encodes to a protein required for invasive 
growth and biofilm formation. In addition, Snf1 inhibits the function of Nrg1 and Nrg2, two 
negative regulators of FLO11, in response to glucose depletion. This data suggests that 
pseudohyphal growth and invasive growth depend on Snf1 activity (Kuchin et al. 2002). Since 
SNF1 and NRG genes are sustained in C. albicans it is hypothesized that this regulatory 
mechanism is functionally conserved. Thus, in this pathogenic fungus, Snf1 plays a role in the 
morphological transition from yeast form to filamentous growth, a process that is vital for the 
pathogenicity of C. albicans (Kuchin et al. 2002).  
A role in C. neoformans virulence is also ascribed to Snf1. In this organism, the link of Snf1 
with virulence might be also in part associated with the production of the pigment melanin, a 
cell wall-associated virulence factor, since snf1 mutant strains presented reduced melanin 
production at 37ºC (Hu et al. 2008). Melanin production is regulated by the activity of the 
copper-containing polyphenolic oxidase laccase, majority promoted by the LAC1 gene. LAC1 
transcription is enhanced by glucose starvation, yet by undisclosed mechanisms; 
nevertheless, it is suggested that Snf1 participates in the LAC1 derepression by glucose 
depletion (Yang et al. 2010a). 
Adhesion capacity is another important feature for fungus pathogenicity because it is able to 
mediate the interaction between colonies as well as host–pathogen interactions (Ramsook et 
al. 2010). Concerning this pathogenicity feature, it was demonstrated, in vitro, that SNF1 
abrogation in C. neoformans impairs the cells ability to adhere to agar in comparison with 
control strains (Yang et al. 2011). Furthermore, the same study also demonstrated that snf1 
mutant cells presented a phonotype compared with cell wall defects, since they are sensitive 
to SDS and Congo red (Yang et al. 2011). Thus, Snf1 apparently has also a contribution 
concerning the modulation of the cell wall integrity that functions as essential barrier to protect 
cells from harmful effects caused by the extreme conditions frequently face by fungal cells 
(Bermejo et al. 2008; Levin 2005; Waterman et al. 2007). Together, the data suggests that the 
observed cell wall impairment observed in the absence of Snf1 might cause changes of the 
cellular surface components such as glycoproteins which could lead to the loss of adhesion 
capacity; nevertheless, the adhesion regulation pathways in C. neoformans are yet 
undisclosed. 
The kinase Snf1 functions are well characterized in the yeast S. cerevisiae ,a model organism 
in which it was demonstrated that this kinase has a central metabolic function. At the same 
regulation level, several studies in important human pathogenic fungi showed that Snf1 
homologs presented a conserved function, evidencing that this protein can be a potential 
antifungal target. More interestingly, several observations point out Snf1 as a regulator of 
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virulence factors as well as a virulence factor. Concerning this aspect, Snf1 is able to 
modulate crucial fungal pathogenic mechanisms, as above discussed; nevertheless and due 
to its crucial role in the cells viability, new approaches must be developed in an attempt to 
disclose the precise pathogenic mechanism regulated by Snf1. Together, all the pieces of 
information highlighted that Snf1 might represent a promising alternative target of interest to 
drug development. 
 
FINAL REMARKS 
Host–pathogen interactions are highly dynamic processes where both compete to acquire a 
myriad of essential nutrients, crucial to survive inside an infection niche. Although it seems 
well established that pathogens manipulate host metabolism in its own advantage, the 
preferred nutrient sources and the triggered metabolic pathways are still to be completely 
understood. In this context, the manipulation of host AMPK activity seems to be a valuable 
approach for controlling pathogen burden and infection progression. 
The positive or negative impact on host AMPK protein during an infection could reflect the 
existence of distinct biological and nutritional needs for the distinct pathogens. Overall, two 
main factors contribute for the different responses observed concerning host AMPK 
modulation during infection. First, in vivo, microbial pathogens can find distinct niche/cells with 
different nutritional/immunological status. Secondly, an heterogeneity in host–pathogen 
interactions (various pathogens subsets) could occur simultaneously within the same host 
tissue reflecting disparate outcomes (Bumann 2015). We can then speculate that pathogen 
survival will depend on the ability to sense and find the most permissive cells without 
discarding the overall contribution of the different pathogen subsets within the same tissue. 
This vast heterogeneity during in vivo infections set the nutrient sensors, as AMPK, in a more 
privileged core to impact on the disease outcome. Moreover, an additional diversity in terms of 
AMPK/SNF1 orthologues function was described within parasites and fungal organisms. The 
particularities of each parasite or fungus life cycle and the pressure exerted by the different 
hosts could guide the evolutionary process of these orthologues in distinct branches of the 
phylogenetic tree that could account ultimately for their variability inside these organisms. In 
that sense, the parasite and fungal AMPK/SNF1 members could participate in the intracellular 
sensing of the nutritional status of the host. Thus, a rearrangement of their metabolic 
pathways may occur in order to acquire the sufficient amount of nutrients and energy from the 
host to survive. Nevertheless, the role for AMPK/SNF1 orthologues during the infectious 
process still remains uncomprehend. 
The quite unexplored field of nutrient sensors open a new avenue to exploit AMPK as a 
possible drug target against microbial pathogens. The design of new drugs to activate or 
inhibit this kinase in the host during infection could be an interesting domain to explore. In fact, 
there are drugs currently used to treat metabolic diseases that could be considered an 
alternative approach to treat infectious diseases. A classic example is metformin, which is 
able to activate AMPK through mitochondria complex I inhibition that is currently the most 
common treatment for diabetes type 2. Although due to the large variation described in terms 
of niche/cells and the presence of various pathogen subsets during in vivo infections, several 
concerns are being raised. The described disparities may account for the unsuccessful 
treatment or resistance development found in conventional therapeutics. The possible 
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addition/synergy of AMPK activators or inhibitors to the conventional treatment could 
represent a viable and important therapeutic alternative to overcome this infection issue. 
Despite the highly conservation among eukaryotes, AMPK orthologues described in parasites 
and fungi could be also explored as potential drug targets. To develop selective activators or 
inhibitors to these orthologues, the homology to mammals should be low, although relevant 
divergences in the catalytic domain or differences in the protein weight/conformation should 
be considered. As an example, we can speculate that PfKIN from P. falciparum could be 
considered a promising drug target due to the fact that its catalytic domain presents 40 % of 
homology with the SNF1 sequence of S. cerevisiae, and no significant amino acid sequence 
similarities to any other proteins were found outside the catalytic domain. AMPK orthologues 
have been more studied in Plasmodium; however, further work will be needed to characterize 
and define this protein as a possible drug target as well as in other pathogens. 
Overall, the nutritional status of the host and the infection outcome can influence each other 
occupying the microbial pathogens a central position in this dynamic balance. The hallmark of 
the host metabolic status and infection outcome is the gut microbial communities, defined as 
microbiota, which is currently considered a hot research topic. In a healthy state, they 
contribute nutrients and energy to the host, and a balance is maintained with the host’s 
metabolism and immune system. On the other side, intestinal dysbiosis can act as a source of 
inflammation and infection and possible contributions to diabetes mellitus and obesity (Flint et 
al. 2012).This striking regulation could be essential to improve or trace new antimicrobial 
strategies through the modulation of host metabolism. 
FUNDING STATEMENT 
This work was supported by grants to JE from the Agence Nationale de Recherches sur le 
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Figure 12.1. Viral infection induces a differential regulation of AMPK activity. Host AMPK may be modulated in order 
to promote and ease virus entry (e.g., by macropinocytosis) and immune evasion. AMPK modulation results in the 
activation of several downstream targets and consequent host metabolism reprograming. Catabolic processes, as 
fatty acid oxidation and glucose metabolism, are activated through phosphorylation of ACC and increased expression 
of GLUT4, respectively. On the other side, anabolic processes, as protein synthesis and fatty acid synthesis, are 
inhibited. NAMPT-induced activation of SIRT1 originates increased PGC1α-induced transcription of mitochondrial 
genes. Mitophagy may also be induced by AMPK activation, although its role in viral infections has yet to be 
addressed. ACC - acetyl- oA carboxylase, AMPK - AMP- ctivated protein ki ase, CaMKK - β calcium/calmodulin-
dependent protein kinase kinase β, GLUT4 - glucose transporter 4, NAD - nicotinamide adenine dinucleotide, Nampt 
- nicotinamide phosphoribosyltransferase, MKK3/6 - MAPK kinase 3/6, mTOR - mechanistic target of rapamycin, 
LKB1 - liver kinase B1, p38MAPK - p38 mitogen-activated protein kinase, PGC1α - peroxisome proliferator-activated 
receptor γ co-activator-1α, SIRT1 - Sirtuin 1, TSC - tuberous sclerosis, ULK1 - Unc-51-like kinase 1. 
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Figure 12.2. AMPK signaling pathways during host response to bacterial infection. The release of bacterial products 
such as TLR agonists and PFT or the infectious process itself may lead to AMPK activation. This occurs through 
alteration of the intracellular calcium concentration and consequent CAMKKβ activation, decrease of ATP/AMP 
ratios, or ROS production. Additionally, AMPK may also be activated by chemical compounds such as AICAR, 
metformin, and compound. The phosphorylation of AMPK in the threonine residue 172 (Thr172) during bacterial 
infections has multiple effects in energy metabolism and autophagy that ultimately contribute to the resolution or 
progression of the infection. AMPK is a negative regulator of mTOR, so, upon Thr172 phosphorylation, mTOR is 
inhibited, as well as protein synthesis. Furthermore, mitochondrial metabolism is impacted during infection: 
mitochondrial respiration and biogenesis may be indirectly increased during bacterial-induced AMPK activation. 
Furthermore, the transcriptional co-activator PGC-1α is directly modulated by AMPK and originates the increase in 
transcription of autophagy-related genes, thus leading to increased xenophagy. However, the role of xenophagy in 
the disclosure of a bacterial infection is still controversial. On one hand, this antibacterial process may cause 
bacterial death and elimination, through acidification of the intracellular niches and consequent degradation of 
pathogen. On the other hand, it may increase nutrient availability, thus contributing to pathogen survival. Similarly, 
the increase in mitochondrial mass may cause an increase in lipid oxidation, which contributes to increased 
intracellular nutrient availability and, consequently, to proliferation and survival of the pathogen. AICAR - 5-
aminoimidazole-4-carboxamide-1-β-D-ribofuranoside, AMP - adenosine monophosphate, AMPK - AMP-activated 
protein kinase, ATP - adenosine triphosphate, CaMKKβ - calcium/calmodulin-dependent protein kinaseβ, mTOR - 
mechanistic target of rapamycin, PFT - pore-forming toxins, PGC1α – peroxisome proliferator-activated receptor γ 
co-activator-1α, ROS - reactive species of oxygen, TLR - Toll-like receptor. 
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Figure 12.3. Host AMPK dictates parasite infection outcome. (A) In a context of malaria liver stage infection, 
Plasmodium berghei modulates the transcriptional program of the host hepatocytes. Within the host cells, P. berghei 
increases gluconeogenesis enzymes and Prkaa2 (AMPKα), Prkag2 (AMPKγ) transcripts, decreasing in parallel the 
transcription of Pfk glycolytic enzyme. At this stage, an increase of glucose levels is established generating a 
permissive niche for sporozoites survival, which are highly dependent on glucose. (B)) During Leishmania infantum 
infection, the promastigote form induces a metabolic alteration toward a glycolytic environment with a decrease of 
energetic (ATP/AMP) and redox status of the host. The increased AMP levels triggers the activation of AMPK that 
will be phosphorylated by SIRT1-LKB1 pathway which, in this context, is considered an AMPK upstream activator. 
Afterwards, a metabolic rearrangement occurs through the increase of respiration and PGC-1α activation. At this 
point, the energetic and redox pools are recovered leading ultimately to the parasite survival. (C) A detrimental effect 
of AMPK was defined for Nippostrongylus braziliensis persistence within the host. The specific ablation of AMPK in 
dendritic cells deregulated the type 2 response establishing a type 1 through the augmentation of Th17 cells. 
Simultaneously, the ability to alternatively activate macrophages is dampened, concomitantly with the decrease 
capacity to regenerate tissue damage induced by the pathogen. (D) AMPK in a context of T. cruzi infection has also 
a deleterious effect for the pathogen survival and growth. Inside the host, trypomastigotes supports AKT-mTORC1 
pathway activation maintaining in parallel, a high energetic level that consequently ablates AMPK activity. Ultimately, 
the established niche becomes permissive for the amastigotes survival and growth inside the host. Pfk - 
phosphofructokinase 1, ECAR - extracellular acidification rate, OCR - oxygen consumption, SIRT1 - silent mating 
type information regulation 2 homolog 1, LKB1 - liver kinase B1, AMPK-p - AMP-activated protein kinase α-
phosphorylated, PGC-1alpha - peroxisome proliferator-activated receptor gamma coactivator 1-alpha and mTORC1 - 
mammalian target of rapamycin complex 1. 
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Figure 12.4. SNF1 protein kinase in pathogenic fungi. Snf1, AMPK homolog in fungi, functions as an energy sensor 
and allows for a proper response and adaptation to environmental stress. This kinase is activated during low 
ATP/AMP ratio and also by PKA, in an independent fashion. Snf1 activation allows the adaption to limitations on 
glucose availability and prompts the use of other alternative carbon sources, like sucrose, galactose, and ethanol. 
Snf1 ablation results in metabolic impairment and the loss of inability to use different carbon sources, with possible 
consequences in fungi pathogenicity, namely, regarding susceptibility to antifungal therapy and cell wall constitution. 
Furthermore, in glucose deprivation conditions, Snf1 promotes transcription of FLO11 gene, which encodes to a 
protein required for invasive growth and biofilms, thus impacting C. albicans invasion and consequent pathogenicity. 
Snf1 is also responsible for the regulation of melanin production by C. neoformans , which is an important cell wall-
associated virulence factor. AMP - adenosine monophosphate, AMPK - AMP-activated protein kinase, ATP - 
adenosine triphosphate, PKA - cAMP-dependent protein kinase. 
 
